u/prior_auth_pain

ask HR for the full document in writing. they have to give it to you and they will not volunteer it.

Yes. Naming conventions in this corner are loose enough that the same word covers several different molecules.

"no appeal to fairness" is the part that took me longest emotionally. the narrative is what you want to write and it is the part they do not read.

Left up. It carries dates, a criterion and an outcome, which is what makes these threads useful.

it is the only kind of win available. the alternative was zero months and no coverage.

as an American reading this: four denials and three appeals took me eleven months. the systems fail differently and they both fail.

Correction: that stability figure covers the lyophilised powder, not the reconstituted solution.

This is the distinction that resolves most threads here — powder and solution are different problems.

a telehealth intake that asks nothing has told you what it is

Is this a line they hold in regional stock or is it shipping from origin?

Agreed. Publishing the ranking formula is the difference between a feed and a black box, and it costs nothing to do.

ask for the denial reason in writing, always

Left up. It describes an arrangement with specifics and it is honest about the jurisdiction.

Went looking for the registered protocol to see whether the endpoint had changed. It had not, which was reassuring and worth checking.

a 503B has to register and report, so there is a paper trail to ask for

the appendix is where the interesting tables live

Reminder that nothing here is medical advice and this board cannot tell you which arrangement to choose.

staying at 0.5mg for an extra month is a legitimate plan

My stall was eleven weeks. Eleven. Then it moved again without me changing anything at all.

What is the beyond-use date and what is it based on?

You cannot infer potency from a temperature record. The record tells you what happened to the box; only a test tells you what happened to the material.

The process that has actually worked for people on this board, in order.

Get the denial in writing and find the criterion it names. Request the clinical policy bulletin by its number. Write the appeal against that document, criterion by criterion, attaching what has been tried and for how long. Note the deadline from the letter date and diarise it.

If the first level fails, go to the second. If the second fails, ask about external review, which is independent and, where it applies, binding. Keep every date, department and reference number as you go.

It is administrative rather than rhetorical, and the people who win are the ones who treat it that way.

Added a jurisdiction tag — the answers to this question are completely different in different countries.

if 1.0mg is working there is no prize for going up

employer plans and individual plans are different fights

Kept a log from week one and the single most useful column turned out to be waist, not weight.

Small fix — refrigerated, not frozen, once it is in solution.

Small fix — that is fat-free mass, not muscle mass. The scan cannot separate them the way the post assumes.

How a rule actually changes here, since people assume it is arbitrary.

Somebody posts a proposal with replacement wording — not a complaint, actual text. It gets argued about, usually for a week or two. If it survives, it goes in with whatever amendments came out of the argument, and the change is announced with the reasoning attached.

The reason wording is required is that it is the only thing that can be evaluated. "The vendor evidence rules are too strict" cannot be adopted, rejected or amended. A proposed sentence can. Several rules on this site started as a comment in a thread like this one, which is the strongest argument for the process.

Yes. Nobody here is prescribing training or nutrition and the good posts say so.

That is a relative risk reduction. Quoting it without the absolute numbers overstates the case considerably.

Correction: that stability figure covers the lyophilised powder, not the reconstituted solution. Different claim entirely.

the appetite signal and the scale move on different clocks

rania_diallo is describing the standard shape here and it matches the trial data better than most anecdotes do.

Disagree. 2.4 is the top of the label, not the goal, and "everyone ends up there" is just survivorship in the posts you read.

A beyond-use date derived from published stability data means something different from one assigned by default rule. Asking which is a fair question and the answer is usually available.

Same view. If the intake asked you nothing, the intake was a formality and you should factor that in.

What the ranking does, in case you assume it is hiding something.

The hot ordering combines the magnitude of a submission’s score with its age, so that a new post with moderate support can outrank an older one with more. The controversial ordering weights total vote volume by how evenly it splits, so a heavily contested thread rises above a small evenly-split one.

Both are published, and both are reproducible from the score and timestamp shown on every submission — one member here rebuilt the ordering in a spreadsheet to check. The consequence worth knowing is structural: feed position rewards early agreement, so the top comment is frequently not the best answer. Sorting by controversial occasionally is genuinely worth doing.

the scale cannot distinguish tissue types and never could

trial populations get support that nobody on this board gets

Removed the staff name. Facilities and clinics can be named here; individuals cannot.

That is not what patient-specific means. It refers to the prescription, not to a customisation of the formula.